Merika Koday, Ph.D.


Dr. Merika Koday joined Accelerator Life Science Partners in 2019 and serves as an Associate.  She is a member of the Science & Development Team which is responsible for sourcing and evaluating emerging biotechnology investment opportunities.  She also provides project management and scientific development oversight to select ALSP I portfolio companies, including ApoGen Biotechnologies, Rodeo Therapeutics (acquired by Amgen Inc.), and Lydian Neurosciences.

Prior to joining Accelerator, Dr. Koday served as Project Manager for the Program for Cell and Gene Therapy at Seattle Children’s Research Institute, where she helped to advance basic research programs into clinical development and supported industry partnerships and collaborations.  Prior to her role at Seattle Children’s Research Institute, Dr. Koday was a co-founder and Senior Scientist at Virvio, a University of Washington spin- out company focused on the development of de novo designed proteins as therapeutic alternatives to monoclonal antibodies.